569
Views
13
CrossRef citations to date
0
Altmetric
Research Articles

Carbamazepine and levetiracetam-loaded PLGA nanoparticles prepared by nanoprecipitation method: in vitro and in vivo studies

, , ORCID Icon, , , & show all
Pages 1063-1072 | Received 18 Feb 2020, Accepted 06 May 2020, Published online: 27 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Busra Kandilli, Afife Busra Ugur Kaplan, Meltem Cetin, Numan Taspınar, Sidika Genc, Yesim Yeni, Muhammed Sait Ertugrul, Ismail Cagri Aydin & Ahmet Hacimuftuoglu. (2021) Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization. Drug Development and Industrial Pharmacy 47:7, pages 1153-1165.
Read now

Articles from other publishers (12)

Mansi Athalye, Divya Teli, Mehul Chorawala, Abhilasha Sharma, Rashmin Patel, Kamal Dua, Sachin Kumar Singh, Gaurav Gupta & Mrunali Patel. (2024) Apolipoprotein E3 functionalized lipid-drug conjugated nanoparticles of Levetiracetam for enhanced delivery to the brain: In-vitro cell line studies and in-vivo study. International Journal of Biological Macromolecules 254, pages 127799.
Crossref
Hima Sree Buddhiraju, Jayalakshmi Balaraman, Dheeraj Dehariya, Monika Pebam, Kalyani Eswar & Aravind Kumar Rengan. (2023) PLGA nanoparticle loaded with antioxidants and photosensitizer for ROS shock mediated phototherapy of triple negative breast cancer. Biomedical Materials 18:6, pages 065002.
Crossref
Mansi Athalye, Divya Teli, Abhilasha Sharma & Mrunali Patel. (2023) Anti‐Epileptic Drug‐Lipid Conjugates for Delivery to the Brain: In Silico ADMET Prediction, Molecular Docking and Molecular Dynamics Simulations. ChemistrySelect 8:34.
Crossref
Afife Busra Ugur Kaplan, Meltem Cetin, Cemil Bayram, Serkan Yildirim, Ali Taghizadehghalehjoughi & Ahmet Hacimuftuoglu. (2023) In Vivo Evaluation of Nanoemulsion Formulations for Metformin and Repaglinide Alone and Combination. Journal of Pharmaceutical Sciences 112:5, pages 1411-1426.
Crossref
Rebecca Maher, Almudena Moreno-Borrallo, Dhruvi Jindal, Binh T. Mai, Eduardo Ruiz-Hernandez & Andrew Harkin. (2023) Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery. Pharmaceutics 15:3, pages 746.
Crossref
Mariana Matias, Adriana O. Santos, Samuel Silvestre & Gilberto Alves. (2023) Fighting Epilepsy with Nanomedicines—Is This the Right Weapon?. Pharmaceutics 15:2, pages 306.
Crossref
Larissa Silva de Lima, Vinícius Loyola, João Victor Montenegro Luzardo Bicca, Lucas Faro, Camilla Lepesqueur Costa Vale, Bruna Lotufo Denucci & Márcia Renata Mortari. (2022) Innovative treatments for epilepsy: Venom peptides, cannabinoids, and neurostimulation. Journal of Neuroscience Research 100:11, pages 1969-1986.
Crossref
Héctor Hernández-Parra, Hernán Cortés, José Arturo Avalos-Fuentes, María Del Prado-Audelo, Benjamín Florán, Gerardo Leyva-Gómez, Javad Sharifi-Rad & William C. Cho. (2022) Repositioning of drugs for Parkinson’s disease and pharmaceutical nanotechnology tools for their optimization. Journal of Nanobiotechnology 20:1.
Crossref
Huaxi Xiao, Fan Yang, Qinlu Lin, Lin Zhang, Shuguo Sun, Wenhua Zhou & Gao-Qiang Liu. (2022) Preparation of fluorescent nanoparticles based on broken-rice starch for live-cell imaging. International Journal of Biological Macromolecules 217, pages 88-95.
Crossref
A. Salesa, L.M. Esteban & C. Barris. (2022) Confinement of FRP concrete columns: Review of design guidelines and comparison with experimental results. Materiales de Construcción 72:345, pages e274.
Crossref
A. Alper Öztürkİrem NamlıAbdurrahman Aygül. (2021) Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity. ASSAY and Drug Development Technologies 19:3, pages 156-175.
Crossref
Ikram Ahmad, Hina Tabassum, Farwa Batool Shamsi, Saad Maroof Saeed, Awais Ahmad & Shahid Hussain. 2021. Nanomedicine Manufacturing and Applications. Nanomedicine Manufacturing and Applications 173 191 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.